Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-022219

President and CEO sold 5,407 shares at an average $0.68 ($3,702)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-08-04 Sale : show line 1 in the form 10b5-1 −2,550 $0.69 $1,760 664,792 D
2023-08-07 Sale : show line 2 in the form 10b5-1 −2,857 $0.68 $1,943 661,935 D
Open-market sales · 5,407 sh · avg $0.68 · $3,702
Loading xslF345X05/form4.xml…